Skip to content

A Cognitive-Augmented Mobility Program

A Cognitive-Augmented Mobility Program (CAMP): Combining Cognitive Strategy Training And Best Evidence Mobility Training To Optimize Long-Term Meaningful Living For People With Stroke

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03683160
Acronym
CAMP
Enrollment
10
Registered
2018-09-25
Start date
2017-03-01
Completion date
2018-01-31
Last updated
2018-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Stroke, mobility, cognitive strategy training

Brief summary

This project will combine best-evidence gait and mobility training with best evidence cognitive strategy training to produce a new cognitive-augmented mobility intervention that is expected to optimize long-term functional mobility outcomes for those living with stroke. More importantly, the new cognitive-augmented mobility program (CAMP) will address two crucial outcomes that do not occur with current approaches: 1. Maintenance of mobility gains after discharge from formal rehabilitation and 2. Transfer of skills learned in rehabilitation to real-world community living. This project will result in a new, fully defined intervention, and will provide effect size and cost estimates to design a future appropriately powered randomized controlled trial (RCT).

Detailed description

Difficulty walking is a leading cause of activity restriction in survivors of stroke. It is directly related to important functional issues, such as challenges in crossing a street in time, difficulty walking to a bus stop and increased risk of falls. These functional issues can then impact a person's confidence to move around their community, ultimately leading to lower levels of physical activity and potential negative health consequences. The best way to optimize recovery in walking and mobility is not yet known, and there are critical gaps in existing treatments. While some approaches are effective in the short term, strategies to promote the maintenance of improvements are not well established, benefits are usually not transferred beyond the specific skills trained and the specific context in which they were learned, few interventions impact community participation, and cost effectiveness has rarely been investigated. A potential solution exists in combining best-evidence interventions: task-specific gait and mobility training to improve skill quality, cardiorespiratory and strength exercises to improve endurance and speed, and cognitive strategy training to teach problem solving, improve confidence and to ensure long-term maintenance and transfer of skills to home and community settings. The investigators will combine best evidence mobility interventions with best evidence cognitive strategy training to develop and evaluate a new intervention to optimize long-term functional mobility outcomes for those living with stroke. The project consists of two sequential stages: 1) intervention development through literature synthesis; face validity testing using focus groups with patients, family members and expert stroke rehabilitation clinicians; and intervention refinement; followed by 2) feasibility/pilot testing with 10 people more than 6 months post stroke. Anticipated outcomes include a fully developed intervention with the potential to optimize mobility rehabilitation and effect size estimates to permit the design of a future, appropriately-powered randomized controlled trial.

Interventions

OTHERCognitive Augmented Mobility Program

CAMP will combine education, one-on-one cognitive strategy training, and a cardiovascular and strength-training program conducted within a group setting. It will be run as a group of up to 6 participants, facilitated by a physiotherapist and a physiotherapy assistant or kinesiologist. It consists of 2 phases with a total of 19 sessions: Intervention Preparation (3 sessions), Active Intervention (16 sessions), and Follow-Up (1 session).

Sponsors

Sunnybrook Health Sciences Centre
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Single arm design with two blocks.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients aged 18 years of age or older * post stroke * have completed outpatient therapy * can walk a minimum of 3 metres with or without an aid

Exclusion criteria

* patient does not a mobility goal * neurological diagnoses other than stroke * major psychiatric illness * significant dementia (MoCA scores \< 21)

Design outcomes

Primary

MeasureTime frameDescription
Mean Canadian Occupational Performance Measure scores1) 1 week pre-intervention; 2) 1 week post-intervention, 3) 4 to 5 weeks post-interventionThe Canadian Occupational Performance Measure (COPM) is a self-report measure of performance and satisfaction with self-selected goals. Participants are asked to generate 5 personally meaningful rehabilitation goals and rate their current performance and satisfaction on a scale from 1 to 10. Total scores are the average performance and satisfaction score. Higher scores indicate better outcomes.

Secondary

MeasureTime frameDescription
Mean 6-minute walk test scores1) 1 week pre-intervention; 2) 1 week post-intervention, 3) 4 to 5 weeks post-interventionMeasure of walking endurance in metres walked. Higher scores indicate greater distance traveled.
Mean Berg Balance Scale scores1) 1 week pre-intervention; 2) 1 week post-intervention, 3) 4 to 5 weeks post-interventionThe Berg Balance Scale (BBS) is a measure of static balance. Participants are asked to complete a series of 14 tasks and are scored from 0 to 4. Total score (min=0; max=56) is calculated by adding the scores of the individual tasks, higher scores indicate better outcomes.
Mean Activity-specific Balance Confidence Scale scores1) 1 week pre-intervention; 2) 1 week post-intervention, 3) 4 to 5 weeks post-interventionThe Activity-specific Balance Confidence (ABC) Scale is a self-report measure of confidence to perform daily activities without falling. Participants assign a score from 0 to 100 to each of the measure's 16 items and the total score is calculated by obtaining the average score. Higher scores indicate better outcomes.
Mean Community Balance and Mobility Scale scores1) 1 week pre-intervention; 2) 1 week post-intervention, 3) 4 to 5 weeks post-interventionThe Community Balance and Mobility (CB&M) Scale is a measure of balance and mobility. Participants are asked to perform 13 tasks while a therapist scores their performance. Several tasks require using both sides. The total score (min=0; max=96) is the sum of all task scores and greater scores indicate better outcomes.
Mean Functional Independence Measure scores1) 1 week pre-intervention; 2) 1 week post-intervention, 3) 4 to 5 weeks post-interventionThe Functional Independence Measure (FIM) is a measure of the amount of assistance required to complete activities of daily living. Participants are asked about the amount of assistance required to complete each of the measure's 18 items and are assigned a score from 1 to 7 for each item. Total scores (min=18; max=126) are the sum of the item scores and greater scores indicate better outcomes.
Mean Stroke Impact Scale scores1) 1 week pre-intervention; 2) 1 week post-intervention, 3) 4 to 5 weeks post-interventionThe Stroke Impact Scale (SIS) is a self-report measure of perceived impact of stroke on function and everyday life. The SIS is a 56 item measure with 8 subscales measuring strength, hand function, ADL/IADL, mobility, communication, emotion, memory and thinking, and participation/role function. Subscale scores range from 0 to 100. Greater scores indicate better outcomes.
Mean 5 metre walk test scores1) 1 week pre-intervention; 2) 1 week post-intervention, 3) 4 to 5 weeks post-interventionMeasure of gait speed in metres per second. Higher scores indicate faster walking speed.

Other

MeasureTime frameDescription
Feasibility - Number of participants who attend the intervention sessionThrough study completion, up to 9 monthsTotal number of participants who attend the intervention sessions
Feasibility - Number of participant withdrawalsThrough study completion, up to 9 monthsNumber of participant withdrawals and reasons, if any
Feasibility - Number of adverse eventsThrough study completion, up to 9 monthsTotal number of adverse events and reasons, if any
Feasibility - Number of participants recruitedThrough study completion, up to 9 monthsTotal number of participants enrolled in the study
Acceptability - Participant satisfaction and intent to use1 week post-interventionParticipants will be asked to complete a 2 question survey to gauge their satisfaction with the intervention and their interest in using the skills they learned during the intervention. Scores for each item range from 1 to 5. Higher scores indicate greater satisfaction and intention to use the skills they learned in the future.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026